Biotechnology in Argentina: Development and Resources

Authors

  • Claudia Zylberberg Akron Biotechnology
  • Asli Ceylan Oner Florida Atlantic University
  • Ezequiel Zylberberg Ezequiel Zylberberg holds an MSc in Development Studies from the London School of Economics and Political Science. His studies focused on the political economy of Latin America and on development history, theory and policy. Primary research interests include global value chains and industrial development, smallholder-inclusive business models and developmental states. He has conducted primary research on global value chains in Latin America and Eastern Africa.

DOI:

https://doi.org/10.5912/jcb528

Keywords:

Biotechnology, research and development, innovation, Argentina

Abstract

Biotechnology related developments in Argentina have gained momentum in the past few years. The creation of the Ministry of Science, Technology and Innovative Production in 2007 that focuses on high-tech growth in technology related fields including biotechnology, demonstrates the public sector commitment to a field with a thriving business sector and promising improvements in research and development. By embracing its agricultural advantage and investing in research and innovation, Argentina has seen its stock of biotech companies grow to 120, of which 90 percent are domestic small and medium size. Today, biotechnology researchers in Argentina engage in international collaboration with other scholars and globally recognized institutions and the country has bilateral agreements with other countries to support biotechnology related research and development. There are many governmental and non-profit organizations that are influential in shaping Argentina’s vision on biotechnology. Although the government places importance in providing support in biotechnology research, innovation and investment, the paper argues that the rapid growth trends in the industry requires biotechnology to become higher on the national agenda. The lack of a royalty collection system, the absence of patent protection, and the inadequate sources of venture capital still remain as important problems. Attracting new forms of foreign capital, higher investment in infrastructure, building on existing regional and global networks in research and development, are all important areas for improvement to advance biotechnology in Argentina.

 

Author Biographies

  • Claudia Zylberberg, Akron Biotechnology

    Claudia Zylberberg, PhD, serves as Chief Executive Officer and President of Akron Biotechnology. She also co-founded Akron Clinical, LLC, a clinical CRO specializing in cell therapy clinical trials in Latin America and AssureImmune, an adult stem cell bank that engages in R&D of cell therapies where she serves as Director of the Scientific Advisory Board. With a PhD in Biotechnology from the University of British Columbia, Vancouver, Canada and University of Buenos Aires, Argentina, Dr. Zylberberg has over 25 years of experience in the international biopharmaceutical industry. Her expertise is focused on the areas of recombinant protein production and human-derived blood products.  She has authored and co-authored many scientific articles and developed several commercial products for use in the field of cellular biology. She is a member of scientific committee for Alliance of Regenerative Medicine, US Pharmacopeia scientific advisory for ancillary products, BioFlorida Board of Directors, and other local and international organizations.

  • Asli Ceylan Oner, Florida Atlantic University

    Dr. Asli Ceylan Oner is an assistant professor in the School of Urban and Regional Planning (SURP) at Florida Atlantic University located in Fort Lauderdale, Florida, U.S.A. Dr. Oner’s research interests include globalization and planning and governance of global cities, locational strategies of transnational advanced producer service firms, the role of high-tech industries and knowledge economy in global urban competitiveness, and comparative urbanization. Dr. Oner has published articles and book chapters in topics related to transnational firms and global urban networks. She also took part in various projects in Globalization and World Cities Research Group (GaWC) related to globalization and in the Metropolitan Institute of Virginia Tech related to metropolitan decentralization of the US cities. Dr. Oner teaches graduate and undergraduate courses in SURP. She is also the coordinator for the Bachelor of Urban and Regional Planning Program in the same school.

     

References

Gutman, G., Lavarello, P. and Cajal J. (2006) La biotecnología y las industrias de ingredientes alimentarios en Argentina. Journal of Technology Management & Innovation, I(3): 121-130.

Guillermo, A., Bisang, R. and Stubrin, L. (2010) Las empresas de biotecnología en Argentina. UN: CEPAL - Coleccion Documentos de Proyectos. December 2010.

Ferrand, Y., Kelton, C.M.L., Chen, K., and Stafford, H.A. (2009) Biotechnology in Cincinnati: Clustering or Colocation? Economic Development Quarterly. 23 (2): 127-140.

Gertler, M.S. and Vindorai, T. (2009) Life Sciences and Regional Innovation: One Path or Many? European Planning Studies. 17 (2): 235-261.

Sherwin, S. (2011) Dr. Stephen Sherwin, BIO Chairman and Chairman & Co-founder of Ceregene, Addresses Attendees at BIO International Convention. http://www.bio.org/advocacy/letters/dr-stephen-sherwin-bio-chairman-and-chairman-co-founder-ceregene-addresses-attendee (accessed October 2011).

Ernst&Young. (2011) Beyond Borders: Global Biotechnology Report 2011. http://www.ey.com/Publication/vwLUAssets/Beyond_borders_global_biotechnology_report_2011/$FILE/Beyond_borders_global_biotechnology_report_2011.pdf (accessed October 2011).

Biotech-Tailor-made for Israel. http://www.mfa.gov.il/MFA/InnovativeIsrael/Biotech-tailor_made_for_Israel_%28Nov-2010%29.htm (accessed October 2011).

Randall, J. (2000) Despite Embargo, Biotechnology in Cuba Thrives. JNCI J Natl Cancer Inst 92 (13): 1034-1037.

ProsperAR. (2009) Biotechnology in Argentina: Knowledge + Innovation to meet global market needs. http://www.slideshare.net/ProsperArgentina/biotechnology-in-argentina (accessed October 2011).

USDA. (2010) Argentina: Biotechnology GE Plants and Animals 2010 Annual Biotechnology Report. http://gain.fas.usda.gov/Recent%20GAIN%20Publications/Biotechnology%20-%20GE%20Plants%20and%20Animals_Buenos%20Aires_Argentina_1-13-2011.pdf (accessed October 2011).

Science and Technology; Perspective of Argentina’s Government. Presentation by Alejandro Ceccatto Deputy Minister of ST&I. http://www.mincyt.gov.ar/multimedia/archivo/archivos/Presentacion_Ceccatto.pdf (accessed October 2011).

BIOTECSUR. (2008) Inventory of Biotechnological Rules and Regulations in the MERCOSUR. http://docs.biotecsur.org/informes/en/inventario/4_normativa_ms.pdf (accessed October 2011).

Data Source: ProsperAR. (2009) Biotechnology in Argentina: Knowledge + Innovation to meet global market needs. http://www.slideshare.net/ProsperArgentina/biotechnology-in-argentina (accessed October 2011).

Data Source: BIOTECSUR. (2008) Inventory of Biotechnology Capacities. http://docs.biotecsur.org/informes/en/inventario/2_capacidades_ms.pdf (accessed October 2011).

Richards, D.G. (2010) Contradictions of the ‘New Green Revolution’: A View from South America's Southern Cone. Globalizations, 7(4): 563-576.

Argentina Israel Cooperation Program. http://www3.matimop.org.il/1/foreign/argentina-israel.asp (accessed October 2011).

Battelle. (2011) 2011 Global R&D Funding Forecast. http://www.battelle.org/aboutus/rd/2011.pdf (accessed October 2011).

Data Source: Battelle. (2011) 2011 Global R&D Funding Forecast. http://www.battelle.org/aboutus/rd/2011.pdf (accessed October 2011).

BIOTECSUR (2008) Inventory of Biotechnology Capacities. http://docs.biotecsur.org/informes/en/inventario/2_capacidades_ms.pdf (accessed October 2011).

FONCyT. http://www.Agencia.gov.ar/SPIP.php?article28 (accessed November 2011).

FONARSEC. http://www.Agencia.gov.ar/SPIP.php?article995 (accessed November 2011).

ORGANIGRAMA. http://www.mincyt.gov.ar/ministerio/estructura/organigrama/index.php (accessed November 2011)

CONICET. http://www.conicet.gov.ar/web/conicet/inicio (accessed October 2011).

The National Agency for the Promotion of Science and Technology of Argentina (ANPCYT) - Biotecnology 2005: Patents for SMEs Grant Call. http://www.insme.org/tenders-calls/280 (accessed November 2011).

ARGEN BIO. http://www.argenbio.org/ (accessed October 2011).

FAB. http://www.foarbi.org.ar/ppal/english.php (accessed October 2011).

CEBIGEVE. http://fundacion-antama.org/cebigeve-nuevo-centro-binacional-de-genomica-vegetal/ (accessed October 2011).

Polo Cientifico Tecnologico. http://www.polo.mincyt.gob.ar/ (accessed November 2011).

Erber, F.S. (1999) Structural Reforms and Science and Technology Policies in Argentina and Brazil. Paper prepared for the seminar "Políticas para fortalecer el Sistema Nacional de Innovación: La experiencia internacional y el camino empreendido por la Argentina", organised by the Secretaria de Ciencia y Tecnologia, Buenos Aires, September. http://cdi.mecon.gov.ar/biblio/docelec/cyt/er.pdf (accessed October 2011).

BIOTECSUR. http://www.biotecsur.org/ (accessed October 2011).

CABBIO.http://www.mincyt.gov.ar/busqueda/index.php?Id_modulo=11&Id_idioma=1&Id_tag=274&nombreTag=CABBIO (accessed October 2011).

Lanteri, L. (2008) Argentina’s Soybean Acreage Response to Changes in Price Incentives. Central Bank of Argentina, Economic Essays. 52 (October-December).

Manfroni, M. (2010) La soja BT RR ya está madura, pero sigue en lista de espera. La Nacion 17 April. http://www.lanacion.com.ar/1254859-la-soja-bt-rr-ya-esta-madura-pero-sigue-en-lista-de-espera (accessed December 2011)

"Beneficios de la Introducción de Nuevas Tecnologias de Soja" Seminario de la Asociasion Semilleros Argentinos, 12/7/2011 en Buenos Aires http://www.asa.org.ar/index.asp (accessed December 2011)

Kesan, J.P. and Gallo, A.A. (2005) Property rights and incentives to invest in seed varieties: Governmental regulations in Argentina. AgBioForum. 8(2&3): 118-126. http://www.agbioforum.org.

The Economist (2011) Cristina Prepares to Defy Gravity. 17 December. http://www.economist.com/node/21541850 (accessed December 2011)

Published

2012-07-01

Issue

Section

Article